BioCryst Pharmaceuticals Inc (NASDAQ:BCRX)
| 7.25 Delayed Data As of 3:59pm ET |  -0.275 / -3.66%Today’s Change | 6.62 Today|||52-Week Range 14.50 | -36.89% Year-to-Date |
Five Year Financial Summary
| All Currency in US Dollars | 4 Year Trend | |||||
|---|---|---|---|---|---|---|
2015 | 2016 | 2017 | 2018 | |||
| Revenue and Income | Net Revenues | 48.3M | 26.4M | 25.2M | 20.7M | |
| Cost of Goods Sold | 1.7M | 2.2M | 998.0K | 86.0K | ||
| Depreciation And Amortization | 180.0K | 483.0K | 704.0K | 770.0K | ||
| Operating Expenses | Gross Income | 46.4M | 23.7M | 23.5M | 19.8M | |
| General Expenses | 85.8M | 72.3M | 80.9M | 103.0M | ||
| Research And Development | 72.8M | 61.0M | 67.0M | 84.9M | ||
| Total Operating Expenses | 87.7M | 75.0M | 82.6M | 103.9M | ||
| Non-Operating Expenses | Operating Income | -39.4M | -48.6M | -57.4M | -83.2M | |
| Extraordinary Charge | -564.0K | -843.0K | -821.0K | -11.1M | ||
| Interest Expense On Debt | 5.2M | 6.5M | 8.6M | 10.1M | ||
| Other Expenses | 1.7M | 11.0K | 1.0K | 943.0K | ||
| Income Taxes, Minority Interest and Extra Items | Pre-Tax Income | -43.0M | -55.1M | -65.8M | -101.3M | |
| Net Income | -43.0M | -55.1M | -65.8M | -101.3M | ||
| Shares To Calculate EPS | Shares To Calculate EPS | 72.9M | 73.7M | 84.5M | 103.2M | |
| Shares To Calculate EPS Diluted | 72.9M | 73.7M | 84.5M | 103.2M | ||
| Earnings Per Share | EPS | -$0.59 | -$0.75 | -$0.78 | -$0.98 | |
| EPS Diluted | -$0.59 | -$0.75 | -$0.78 | -$0.98 | ||
